Vaxcel Polymyxin E 1M IU Powder for Injection, Infusion or Inhalation is indicated in the treatment of the following infections where sensitivity testing suggests that they are caused by susceptible bacteria: Treatment by inhalation of Pseudomonas aeruginosa lung infection in patients with cystic fibrosis (CF).
Intravenous administration for the treatment of some serious infections caused by Gram negative bacteria, including those of the lower respiratory tract and including those of the lower respiratory tract and urinary tract, when more commonly used systemic antibacterial agents may be contra-indicated or may be ineffective because of bacterial resistance.
Sign Out